助手标题
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
共[12]条 当前为第1条到12条
 

相关语句
中成药
    After one year,24hupQ, ALB, TG,C3 antids-DNA, ANA were significiant difference treating group,which indicated Yiqihuoxue Fang was better than the Chinese patent medicine in raising ALB, C3, C4, HGB and decreasing 24hupQ, antids-DNA, ANA, SCr , BUN, TG, Cho1, And had a better effect for LN especially for longer time.
    一年后24hupQ、ALB、TG、C_3、抗ds-DNA、ANA较治疗前有显著性差异(P<0.01),表明益气活血方在升高ALB、C_3、HGB、降低24hupQ、抗ds-DNA、ANA、SCr、BUN方面均优于对照中成药。 在治疗IN上有较好的长程疗效。
    Results: The total effective rate was 98. 00% in the treatment group. 85. 11% in the Chinese patent medicine group and 98. 04% in the western medicine control group.
    结果:治疗组总有效率98.00%,中成药组总有效率85.11%,西药组总有效率98.04%。
    The Study of Prior Traditional Chinese Patent Medicine for Ischemic Stroke
    中成药治疗缺血性脑卒中的优势药物研究
    Contents of trace and constant elements and therapeutic effects of Chinese patent medicine on cardio-cerebral vascular disease:fuzzy classified principle
    治疗心脑血管疾病中成药微量和常量元素含量与疗效的模糊分类法则(英文)
    Methods:60 cases of Menstruation delay were divided into two groups randomly as Traditional Chinese Medicine treatment group and Chinese patent medicine cyclic therapy control group,each of them contained 30 cases and was given CT and patent medicine according to each stadge of menstruation cycle respectively for orally taking.
    选用60例门诊确诊为月经后期的患者,随机分为中药周期疗法组(治疗组)和中成药周期疗法组(对照组),每组30例,两组患者年龄、病程、病情、临床症状等通过统计学处理均无显著性差异(P>0.05);
    Methods: The patients of acute and chronic bronchitis were randomly divided into treatment group, Chinese patent medicine control group and western medicine control group, and they were treated respectively.
    方法:将诊断符合《临床疾病诊断依据治愈好转标准》的急慢性支气管炎患者以不透光信封方式随机分为治疗组、中成药组和西药组进行对照观察。
    but there was a significant difference between the treatment group and the Chinese patent medicine control group (P < 0. 01) .
    治疗组与中成药组比较痊愈率、显效率、总有效率差异有显著性(P<0.01)。
    Tong xinlou is one Chinese patent medicine that can improve the heart function, regulate the level of lipids, make the atheromatous plaque stable and reduce the occurrence of acute coronary syndrome.
    通心络是目前临床上应用的一种中成药,具有改善心功能、调节血脂、稳定斑块、减少急性冠状动脉综合征发生的作用。
    RESULTS: Annual marketing amount of money of Chinese patent medicine by mouth for treating angina pectoris showed a decreased trend,but DDDs showed firstly decreased and then increased in our hospital during the period 2002~2004.CONCLUTION: The use of Chinese patent medicine by mouth for treating angina pectoris in our hospital is basically rational.
    结果:2002年~2004年我院口服抗心绞痛中成药的年销售金额呈下降趋势,DDDs呈先下降后上升的趋势。
    Objective To observe the therapeutic effects of Chinese patent medicine “Wenxin keli” on elderly arrhythmia,and to evaluate its safety.
    目的观察口服中成药稳心颗粒治疗老年人心律失常的疗效并评价其安全性。
    (3) Therapy of pain reliefwith Chinese Patent Medicine can impove the living quality and relief pain in patients with advanced cancer.
    3、提高晚期癌症患者生存质量、减轻痛苦的中成药止痛疗法。
    Conclusions: Tianxiangdan is an effective Chinese patent medicine in the treatment of stable angina pectoris,and has good contribution to improve the quality of life of patients.
    结论:天香丹是治疗冠心病心绞痛的有效中成药,能减少心绞痛的发作,可以改善患者生活质量。
 

首页上一页1下一页尾页 

 
CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社